Study to Evaluate the Safety and Efficacy of Two Fixed Dose Combinations of Irbesartan / Amlodipine and Monotherapy After Eight Weeks of Treatment in Subjects With Uncomplicated Mild to Moderate Essential Hypertension.
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Amlodipine; Amlodipine/irbesartan; Irbesartan
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms I-COMBO
- 12 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Feb 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 12 Feb 2010 Actual patient number (284) added as reported by ClinicalTrials.gov.